The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
Open accessAbstract
Enzymes within the P450IIIA (CYP3A) subfamily appear to account for significant "first pass" metabolism of some drugs in the intestine. To identify which of the known P450IIIA genes are expressed in intestine, enterocyte RNA was hybridized on Northern blots with synthetic oligonucleotides complementary to hypervariable regions of hepatic P450IIIA4, P450IIIA5, and P450IIIA7 cDNAs. Hybridization was detected only with the P450IIIA4-specific oligonucleotide. The identity of the hybridizing mRNA was confirmed to be P450IIIA4 by direct sequencing of a DNA fragment amplified from enterocyte cDNA by the polymerase chain reaction. To determine if enterocyte P450IIIA4 is inducible, biopsies of small bowel mucosa were obtained from five volunteers before and after they received 7d of treatment with rifampin, a known inducer of P450IIIA4 in liver. Rifampin treatment resulted in a five- or eightfold mean increase (P < 0.05) in the biopsy concentration of P450IIIA4 mRNA when normalized for content of sucrase isomaltase or intestinal fatty acid binding protein mRNAs, respectively. Rifampin also induced P450IIIA immunoreactive protein in enterocytes in each of the subjects, as judged by immunohistochemistry, and resulted in a 10-fold increase in P450IIIA4-specific catalytic activity (erythromycin N-demethylation) in the one patient studied. Our identification of inducible P450IIIA4 in enterocytes may in part account for drug interactions characteristic of P450IIIA4 substrates and suggests a strategy for controlling entry into the body of a major class of xenobiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The colorimetric estimation of formaldehyde by means of the Hantzsch reaction
Nash, T. (1953) · Biochemical Journal · doi:10.1042/bj0550416 · Cited by 4,371
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
NEBERT, D. W., NELSON, D. R., COON, M. J., ESTABROOK, R. W., FEYEREISEN, R., FUJII-KURIYAMA, Y., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., et al. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.1 · Cited by 1,094
Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89213-x · Cited by 724
Kronbach, T., Fischer, V., & Meyer, U. A. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.87 · Cited by 533
Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F. J., & Meyer, U. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09118-7 · Cited by 532
Clinical Pharmacokinetics of Cyclosporin
Ptachcinski, R. J., Venkataramanan, R., & Burckart, G. J. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611020-00002 · Cited by 493
Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V, Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81632-5 · Cited by 482
Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., & Guzelian, P. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113156 · Cited by 480
Self-citationPichard, L., Fabre, I., Fabre, G., Domergue, J., Saint Aubert, B., Mourad, G., & Maurel, P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08600-3 · Cited by 433
First-pass metabolism of cyclosporin by the gut
Kolars, J. C., Watkins, P. B., Merion, R. M., & Awni, W. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92302-i · Cited by 422
Self-citationStudies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., & Vandenbranden, M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09441-6 · Cited by 402
Watkins, P. B., Murray, S. A., Winkelman, L. G., Heuman, D. M., Wrighton, S. A., & Guzelian, P. S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113933 · Cited by 345
Self-citationGed, C., Rouillon, J., Pichard, L., Combalbert, J., Bressot, N., Bories, P., Michel, H., Beaune, P., & Maurel, P. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03516.x · Cited by 333 · cited 2×
“creased (induced) when patients are treated with a variety of compounds (17, 18), including the commonly used antibiotic rifampin (19-21) .”
BackgroundIdentification of an inducible form of cytochrome P-450 in human liver.
Watkins, P. B., Wrighton, S. A., Maurel, P., Schuetz, E. G., Mendez-Picon, G., Parker, G. A., & Guzelian, P. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6310 · Cited by 317
Self-citationCombalbert, J., Fabre, I., Fabre, G., Dalet, I., Derancourt, J., Cano, J. P., & Maurel, P. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08744-6 · Cited by 306
Oxidation of quinidine by human liver cytochrome P-450.
Guengerich, F. P., Müller-Enoch, D., & Blair, I. A. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10372-6 · Cited by 304
Shimada, T., & Guengerich, F. P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.462 · Cited by 299
Wrighton, S. A., Maurel, P., Schuetz, E. G., Watkins, P. B., Young, B., & Guzelian, P. S. (1985) · Biochemistry · doi:10.1021/bi00330a010 · Cited by 299
Self-citationSweetser, D. A., Birkenmeier, E. H., Klisak, I. J., Zollman, S., Sparkes, R. S., Mohandas, T., Lusis, A. J., & Gordon, J. I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47696-x · Cited by 278
Assay of intestinal disaccharidases
Dahlqvist, A. (1984) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518409161400 · Cited by 276
Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4
Bargetzi, M. J., Aoyama, T., Gonzalez, F. J., & Meyer, U. A. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.180 · Cited by 257
Characterization of Human Microsomal Cytochrome P-450 Enzymes
Guengerich, F. P. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.001325 · Cited by 245
Identification of a polymorphically expressed member of the human cytochrome P-450III family.
Wrighton, S. A., Ring, B. J., Watkins, P. B., & VandenBranden, M. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09114-x · Cited by 228
Self-citationFetus-specific expression of a form of cytochrome P-450 in human livers
Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., & Kamataki, T. (1990) · Biochemistry · doi:10.1021/bi00470a024 · Cited by 201
Biotransformation of lovastatin
Wang, R. W., Kari, P. H., Lu, A. Y. H., Thomas, P. E., Guengerich, F. P., & Vyas, K. P. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90551-s · Cited by 196
Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity
Watkins, P. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040480 · Cited by 188
Self-citationJacolot, F., Simon, I., Dreano, Y., Beaune, P., Riche, C., & Berthou, F. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90131-n · Cited by 179
GONZALEZ, F. J., SCHMID, B. J., UMENO, M., MCBRIDE, O. W., HARDWICK, J. P., MEYER, U. A., GELBOIN, H. V., & IDLE, J. R. (1988) · DNA · doi:10.1089/dna.1988.7.79 · Cited by 164
Beaune, P. H., Umbenhauer, D. R., Bork, R. W., Lloyd, R. S., & Guengerich, F. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8064 · Cited by 158
Murray, G. I., Barnes, T., Hf, S., Ewen, S. W. B., Melvin, W., & Burke, M. D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03331.x · Cited by 147
Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver.
Molowa, D. T., Schuetz, E. G., Wrighton, S. A., Watkins, P. B., Kremers, P. G., MENDEZ-PICON, G., Parker, G. A., & Guzelian, P. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5311 · Cited by 143
Self-citationBork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., & Guengerich, F. P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85029-9 · Cited by 123
Komori, M., Nishio, K., Ohi, H., Kitada, M., & Kamataki, T. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122632 · Cited by 119
Traber, P. G., Yu, L., Wu, G. D., & Judge, T. A. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.262.1.g123 · Cited by 87
Cyclosporin‐erythromycin interaction in renal transplant patients.
Gupta, S. K., Bakran, A., Johnson, R. W. G., & Rowland, M. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05396.x · Cited by 83
CONCOMITANT ADMINISTRATION OF CYCLOSPORIN AND KETOCONAZOLE IN RENAL TRANSPLANT RECIPIENTS
First, M. R., Weiskittel, P. D., Alexander, J. W., Schroeder, T., Myre, S. A., & Pesce, A. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91802-3 · Cited by 73
Cited by
Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
Thummel, K. E., & Wilkinson, G. R. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.389 · Cited by 831
Metadata
- Authors
- Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., & Watkins, P. B.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-11-01
- Volume
- 90
- Issue
- 5
- Pages
- 1871-1878
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2024587809
- Cited by
- 528
- References
- 38
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.